
- Volume 0 0
Ampicillin and Sulbactam for Injection
American Pharmaceutical Partners(Schaumburg, Ill) recently received FDAapproval for its abbreviated new drugapplication for Ampicillin and Sulbactamfor Injection. The product is the genericequivalent of Pfizer Inc's Unasyn. Ampicillinand Sulbactam is an injectableantibacterial combination consisting ofthe semisynthetic antibiotic ampicillinsodium and the beta-lactamase inhibitorsulbactam sodium. The product is indicatedfor the treatment of several skinand skin structure, intra-abdominal, andgynecologic infections due to susceptiblestrains of microorganisms. Administeredintravenously or intramuscularly, Ampicillinand Sulbactam for Injection isavailable in 1.5-and 3-g single-dose vials.The product is preservative-free, andeach vial will include a bar code andlatex-free vial stopper. For more information,visit www.appdrugs.com.
Articles in this issue
over 19 years ago
can you READ these Rxs?over 19 years ago
Compounding HOTLINEover 19 years ago
A Quarter Century of Pharmacy Law—And the Fat Lady Is Singingover 19 years ago
It's Time for Education on Rx Drug Abuseover 19 years ago
Improving Quality of Life for Psoriasis Patientsover 19 years ago
A Look at Diabetic Retinopathyover 19 years ago
The Graying of HIVover 19 years ago
AutoCarouselover 19 years ago
Lexi-Comp Knowledge Solutionover 19 years ago
Refill TeleManagerNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.